Clinical Trial

An Integrated Intervention Using a Pill Ingestible Sensor System

Study acronym: Sensor-SBDOH
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a Los Angeles County HIV clinic, focusing on those at risk for poor adherence. Participants will be randomized into intervention or usual care groups, with endpoints including intervention acceptability, SBDOH interventions, adherence to ART, viral load, and high-risk sexual activity. The study aims to assess the effectiveness of the integrated intervention in improving adherence, virologic outcomes, and reducing high-risk behavior among PLWH.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-24; most recent amendment 2026-02-11.
Status change: Not Yet Recruiting → Recruiting 2025-02-06
Trial Details
NCT Number NCT06480578
Lead Sponsor University of California, Los Angeles
Collaborators: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, EtectRX, Inc., National Institute on Minority Health and Health Disparities (NIMHD)
Conditions HIV/AIDS, Medication Adherence, Social Determinants of Health (SDOH)
Enrollment 110 participants
Start Date 2024-12-19
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13